Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Restoration of HMGN5 expression significantly reversed the inhibitory effects of miR-409-3p overexpression on glioma cell invasion and proliferation.
|
28109076 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In a xenograft model using nude mice, we examined the effects of miR‑409-3p on tumor growth during chemotherapy. miR‑409-3p overexpression sensitized the tumor to chemotherapy, while inhibiting chemotherapy-induced autophagy in a manner dependent on Beclin-1.
|
26935807 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our data collectively indicate that miR-409-3p functions as a tumor suppressor in BC through downregulating Akt1, supporting the targeting of the novel miR-409-3p/Akt1 axis as a potentially effective therapeutic approach for BC.
|
26631969 |
2016 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Our results indicate that miR-409-3p can regulate the invasion and metastasis process of BC by targeting ZEB1 and may serve as a new prognostic marker and therapeutic target for treating BC metastasis.© 2016 IUBMB Life, 68(5):394-402, 2016.
|
27079864 |
2016 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1.
|
26631969 |
2016 |
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Overexpression of miR-409-3p in osteosarcoma cells (U2OS) inhibited cell migration and invasion.
|
26992637 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our results suggest that miR-409-3p functions as a tumor suppressor by inhibiting the development and metastasis of CRC, suggesting that miR-409-3p is expected to become a new diagnostic marker and a new target of the treatment of CRC.
|
26084278 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In this study, we identified miR-409-3p as a tumor suppressor of CRC.
|
25991585 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Strikingly, ectopic expression of miR-409 in normal prostate fibroblasts conferred a cancer-associated stroma-like phenotype and led to the release of miR-409 via extracellular vesicles to promote tumor induction and epithelial-to-mesenchymal transition in vitro and in vivo. miR-409 promoted tumorigenesis through repression of tumor suppressor genes such as Ras suppressor 1 and stromal antigen 2.
|
25065597 |
2015 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
|
25991585 |
2015 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Ectopic expression of miRNA mimics suggested that miR-409-3p could inhibits the abilities of proliferation, wound healing, metastasis and invasion in CRC cells.
|
26084278 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Orthotopic delivery of miR-409-3p/-5p in the murine prostate gland induced tumors where the tumors expressed EMT and stemness markers.
|
24963047 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Low miR-409-3p expression was observed to be significantly correlated with poorer tumor differentiation, advanced pTNM stage and higher incidence of lymph node metastasis.
|
25278243 |
2014 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Functional analyses indicated that miR-409-3p could inhibit growth, induce apoptosis, reduce migration and invasion in LAD cells via inactivation of Akt signaling by targeting c-Met.
|
25278243 |
2014 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These findings indicate that miR-409-3p could be a potential tumor suppressor in bladder cancer.
|
23820886 |
2013 |
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Enforced expression of miR-409-3p in bladder cancer cells significantly reduced their migration and invasion without affecting cell viability.
|
23820886 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
|
22179828 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Taken together, these findings suggest that miR-409-3p may function as a novel tumor suppressor in GC and its anti-oncogenic activity may involve the direct targeting and inhibition of PHF10.
|
22388101 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Taken together, these data demonstrate that miR-409-3p inhibits tumor growth, vascularization and metastasis through down-regulating ANG expression.
|
22531314 |
2012 |
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Enforced expression of miR-409 in GC cells significantly reduced their migration and invasion in vitro and their capacity to develop distal pulmonary metastases and peritoneal dissemination in vivo.
|
22179828 |
2012 |
Malignant Neoplasms
|
0.090 |
AlteredExpression
|
group |
BEFREE |
The aberrant expression of miRNA‑409 (miR‑409) has been found in certain types of cancer, however, its expression and potential biological role in endometrial cancer remain to be fully elucidated.
|
30431090 |
2019 |
Malignant Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
Subsequent in vitro analyses showed a direct involvement of this miRNA in the regulation of E6 oncogene levels, thus confirming a potential tumor suppressor function of miR-409-3p in cervical malignancies.
|
30711417 |
2019 |
Neoplasm Metastasis
|
0.090 |
AlteredExpression
|
phenotype |
BEFREE |
Low miR-409-3p expression levels were associated with clinical stage and distant metastasis in patients with OS.
|
30846940 |
2019 |
Malignant Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
Functional enrichment analysis indicated that these target genes may be involved in the Wnt signaling pathway (miR-409-3p-CTBP1 and miR-339-5p-CHD8) and Proteoglycans in cancer (miR-127-3p-PPP1CA).
|
30013629 |
2018 |
Neoplasm Metastasis
|
0.090 |
AlteredExpression
|
phenotype |
BEFREE |
A significant downregulation was detected in miR-409-3p expression in TSCC tissues and cells (all P<0.05) compared with normal tongue mucosa tissues and cell line, which was associated with lymph node metastasis and tumor-node metastasis staging (both P<0.05).
|
29928443 |
2018 |